Eurospital S.p.A.

VAT NR IT 00047510326
via Flavia 122
Trieste,  34147


Eurospital, an Italian IVD Company, focuses its activities on specific diagnostic sectors such as diagnosis of Coeliac Disease, IBD, detection of genetic predisposition to Coeliac, Type 1 Diabetes and Lactose Intolerance. Actively present worldwide, Eurospital’s aim is to provide Paediatricians, Gastroenterologists and Laboratory Immunologists with highly innovative diagnostic tests such as Calprest family products, Eu-tTG, XeliGen, DiabeGen and LactoGen.